Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,775 | 4 | 61.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,375 | 2 | 25.0% |
| Travel and Lodging | $2,866 | 12 | 11.2% |
| Food and Beverage | $454.87 | 8 | 1.8% |
| Gift | $62.49 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | $19,756 | 21 | $0 (2021) |
| Kyowa Kirin, Inc. | $5,715 | 5 | $0 (2024) |
| Ultradent Products Inc | $62.49 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,721 | 5 | Kyowa Kirin, Inc. ($5,659) |
| 2023 | $56.18 | 1 | Kyowa Kirin, Inc. ($56.18) |
| 2021 | $3,375 | 2 | Ultragenyx Pharmaceutical Inc. ($3,375) |
| 2020 | $7,725 | 3 | Ultragenyx Pharmaceutical Inc. ($7,725) |
| 2019 | $8,656 | 16 | Ultragenyx Pharmaceutical Inc. ($8,656) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Ultradent Products Inc | Opalescence (Device) | Gift | Cash or cash equivalent | $62.49 | General |
| Category: Dental | ||||||
| 10/24/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/24/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $602.20 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/24/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $106.90 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/24/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $49.67 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 05/17/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | In-kind items and services | $56.18 | General |
| 01/25/2021 | Ultragenyx Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| 01/25/2021 | Ultragenyx Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 02/23/2020 | Ultragenyx Pharmaceutical Inc. | Cryvista (Drug) | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 02/23/2020 | Ultragenyx Pharmaceutical Inc. | Cryvista (Drug) | Travel and Lodging | In-kind items and services | $143.69 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 02/21/2020 | Ultragenyx Pharmaceutical Inc. | Cryvista (Drug) | Food and Beverage | In-kind items and services | $81.62 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/13/2019 | Ultragenyx Pharmaceutical Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 09/13/2019 | Ultragenyx Pharmaceutical Inc. | — | Travel and Lodging | Cash or cash equivalent | $152.00 | General |
| 09/13/2019 | Ultragenyx Pharmaceutical Inc. | — | Travel and Lodging | Cash or cash equivalent | $80.00 | General |
| 09/13/2019 | Ultragenyx Pharmaceutical Inc. | — | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| 09/13/2019 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $20.23 | General |
| 09/13/2019 | Ultragenyx Pharmaceutical Inc. | — | Travel and Lodging | Cash or cash equivalent | $19.50 | General |
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| Category: XLH | ||||||
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $676.61 | General |
| Category: XLH | ||||||
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $505.11 | General |
| Category: XLH | ||||||
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $348.00 | General |
| Category: XLH | ||||||
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: XLH | ||||||
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $122.62 | General |
| Category: XLH | ||||||
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $67.58 | General |
| Category: XLH | ||||||
| 07/18/2019 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $62.98 | General |
| Category: XLH | ||||||
About Dr. Raghbir Kaur, DMD
Dr. Raghbir Kaur, DMD is a Pediatric Dentistry healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1679722920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raghbir Kaur, DMD has received a total of $25,534 in payments from pharmaceutical and medical device companies, with $5,721 received in 2024. These payments were reported across 27 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($15,775).
Practice Information
- Specialty Pediatric Dentistry
- Location New York, NY
- Active Since 09/11/2008
- Last Updated 04/03/2013
- Taxonomy Code 1223P0221X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679722920
Products in Payments
- Crysvita (Drug) $11,733
- Cryvista (Drug) $7,725
- Opalescence (Device) $62.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Dentistry Doctors in New York
Dr. Amr Moursi, Dds, DDS
Pediatric Dentistry — Payments: $23,825
Richard Yoon, D.d.s, D.D.S
Pediatric Dentistry — Payments: $23,557
Dr. Lorder Huang, Dds, DDS
Pediatric Dentistry — Payments: $8,960
Dr. Joseph Mcmanus, Dmd, DMD
Pediatric Dentistry — Payments: $6,886
Dr. Christina Carter, Dmd, DMD
Pediatric Dentistry — Payments: $5,719
Dr. Linda Rosenberg, D.d.s, D.D.S
Pediatric Dentistry — Payments: $5,280